Eyes Hospital in Riyadh
The Saudi Ophthalmology Meeting 2020 and its accompanying hypothetical medical exhibition have started, organized by the Saudi Ophthalmology Society, King Khalid Eye Specialist Hospital, and the Department of Ophthalmology, College of Medicine, King Saud University. The CEO of King Khalid Eye Hospital, Dr. Abdulaziz bin Ibrahim Al-Rajhi, welcomed the attendees, and said this meeting is considered a joint meeting for both the annual symposium of the King Khaled Eye Hospital in its thirty-seventh session and the scientific meeting of the Saudi Ophthalmology Society in its thirty-second session, as the hospital plays a major role in Organizing international ophthalmology meetings in Saudi Arabia since 1982.
Al-Rajhi pointed out that the hospital has a long history of excellence and influence in the field of eye care. Since its establishment, more than 81% of eye consultants in Saudi Arabia and 38 ophthalmologists from the Gulf Cooperation Council countries have trained in it, and in early 2019, the hospital obtained institutional re-accreditation of the residency program from the International Council for Accreditation of International Medical Education Programs (ACGME-I), in addition to Institutional accreditation from the Saudi Commission for Health Specialties.
In late 2019, the hospital became the first institution outside the United States and Europe to use Luxturna as a gene therapy to treat retinal dystrophy caused by a defect in the RPE65 gene. This is part of the hospital’s plan to expand the range of services provided to treat congenital and hereditary diseases. The hospital also launched the National Program for the Treatment of Retinopathy of Prematurity (ROP), which aims to preserve the eyesight of more than 400 premature babies annually.
He added that the King Khaled Eye Specialist Hospital is a pioneering institution in the field of research in the region according to the number of research papers in the field of ophthalmology that were published in classified scientific journals, and the total number of projects submitted reached 117 projects and 73 articles published during 2019.
The hospital''s latest achievement was obtaining the seventh level classification for the electronic health file accreditation systems (HIMSS Stage 7), which is based on the classification of electronic medical records and the evaluation of the advanced and comprehensive safety characteristics of medical information. The hospital is also ranked the first in the Middle East and the ninth outside the United States of America to achieve Level 7 in 2017, and is on standby in terms of direct patient care.
The hospital seeks to implement the vision of the Kingdom 2030, as its role is great in developing the care provided in the field of ophthalmology at the national level, and we hope that our impact will reach the regional level, thanks to the sincere dedication, hard work and commitment provided by the work team, and the hospital will continue to be a home for all doctors Laayoune in Saudi Arabia and the region Our services and expertise are within reach for everyone.
Al-Rajhi explained that the goal of the virtual meeting is to organize a comprehensive scientific program that keeps pace with development, in cooperation with our colleagues in both the Saudi Ophthalmological Society and King Saud University, and we offer many thanks and gratitude to everyone who contributed and worked tirelessly behind the scenes for the success of this meeting.
The President of the Saudi Ophthalmology Society, Prince Abdulaziz bin Ahmed, also welcomed the attendees with a speech in which he said: In the name of God, praise be to God, and blessings and peace be upon the Messenger of God, our Prophet Muhammad and his family and companions as a whole,
Brothers and sisters, members of the Saudi Ophthalmology Society - doctors, physicians, specialists and optometrists, distinguished guests, may God’s peace, mercy and blessings be upon you .. I welcome you all to this important virtual scientific meeting in the Saudi Ophthalmology Meeting 2020, and I am glad to accompany this meeting each of (the 32nd annual scientific meeting of the Saudi Society Ophthalmology), and (the 37th symposium of King Khalid Eye Specialist Hospital), with the participation of the Department of Ophthalmology at the College of Medicine at King Saud University, with a group of professors and doctors from Saudi universities and hospitals and from brotherly and friendly countries. Which hosts (13) visiting professors of doctors from different countries of the world, and these scientific efforts are within the vision of the Kingdom 2030.
His Highness added that this hypothetical scientific meeting comes in light of the difficult global conditions of the Corona pandemic that disrupted many aspects of normal life. Among those working in the field of ophthalmology. This virtual meeting reviews the most important new developments in the specialties of ophthalmology, optometry and combating visual impairment, in which members of the association and a large number of participants and followers participate, with the participation of international and national medical companies in the virtual medical exhibition accompanying this specialized scientific meeting.
In conclusion, in the name of all the participants, I extend my gratitude and gratitude to the Custodian of the Two Holy Mosques King Salman bin Abdulaziz - may God support him - and His Highness, the trustworthy Crown Prince - may God protect him - for what they provide for the care of medicine in general and ophthalmology in particular and for the distinguished position of the Kingdom of Saudi Arabia internationally and regionally in everything related Ophthalmology and encouragement of the distinguished capabilities and expertise of Saudi doctors and optometrists. I cannot fail to extend my thanks and gratitude to His Royal Highness Prince Ahmed bin Abdulaziz, Honorary President of the Society, for the sound directions and for the endless care and support of His Highness the Saudi Ophthalmological Society since its inception until now.
81% of eye consultants in Saudi Arabia trained in Al-Ayyun Hospital in Riyadh
The Saudi Ophthalmology Meeting 2020 and its accompanying hypothetical medical exhibition have started, organized by the Saudi Ophthalmology Society, King Khalid Eye Specialist Hospital, and the Department of Ophthalmology, College of Medicine, King Saud University. The CEO of King Khalid Eye Hospital, Dr. Abdulaziz bin Ibrahim Al-Rajhi, welcomed the attendees, and said this meeting is considered a joint meeting for both the annual symposium of the King Khaled Eye Hospital in its thirty-seventh session and the scientific meeting of the Saudi Ophthalmology Society in its thirty-second session, as the hospital plays a major role in Organizing international ophthalmology meetings in Saudi Arabia since 1982.
Al-Rajhi pointed out that the hospital has a long history of excellence and influence in the field of eye care. Since its establishment, more than 81% of eye consultants in Saudi Arabia and 38 ophthalmologists from the Gulf Cooperation Council countries have trained in it, and in early 2019, the hospital obtained institutional re-accreditation of the residency program from the International Council for Accreditation of International Medical Education Programs (ACGME-I), in addition to Institutional accreditation from the Saudi Commission for Health Specialties.
In late 2019, the hospital became the first institution outside the United States and Europe to use Luxturna as a gene therapy to treat retinal dystrophy caused by a defect in the RPE65 gene. This is part of the hospital’s plan to expand the range of services provided to treat congenital and hereditary diseases. The hospital also launched the National Program for the Treatment of Retinopathy of Prematurity (ROP), which aims to preserve the eyesight of more than 400 premature babies annually.
He added that the King Khaled Eye Specialist Hospital is a pioneering institution in the field of research in the region according to the number of research papers in the field of ophthalmology that were published in classified scientific journals, and the total number of projects submitted reached 117 projects and 73 articles published during 2019.
The hospital''s latest achievement was obtaining the seventh level classification for the electronic health file accreditation systems (HIMSS Stage 7), which is based on the classification of electronic medical records and the evaluation of the advanced and comprehensive safety characteristics of medical information. The hospital is also ranked the first in the Middle East and the ninth outside the United States of America to achieve Level 7 in 2017, and is on standby in terms of direct patient care.
The hospital seeks to implement the vision of the Kingdom 2030, as its role is great in developing the care provided in the field of ophthalmology at the national level, and we hope that our impact will reach the regional level, thanks to the sincere dedication, hard work and commitment provided by the work team, and the hospital will continue to be a home for all doctors Laayoune in Saudi Arabia and the region Our services and expertise are within reach for everyone.
Al-Rajhi explained that the goal of the virtual meeting is to organize a comprehensive scientific program that keeps pace with development, in cooperation with our colleagues in both the Saudi Ophthalmological Society and King Saud University, and we offer many thanks and gratitude to everyone who contributed and worked tirelessly behind the scenes for the success of this meeting.
The President of the Saudi Ophthalmology Society, Prince Abdulaziz bin Ahmed, also welcomed the attendees with a speech in which he said: In the name of God, praise be to God, and blessings and peace be upon the Messenger of God, our Prophet Muhammad and his family and companions as a whole,
Brothers and sisters, members of the Saudi Ophthalmology Society - doctors, physicians, specialists and optometrists, distinguished guests, may God’s peace, mercy and blessings be upon you .. I welcome you all to this important virtual scientific meeting in the Saudi Ophthalmology Meeting 2020, and I am glad to accompany this meeting each of (the 32nd annual scientific meeting of the Saudi Society Ophthalmology), and (the 37th symposium of King Khalid Eye Specialist Hospital), with the participation of the Department of Ophthalmology at the College of Medicine at King Saud University, with a group of professors and doctors from Saudi universities and hospitals and from brotherly and friendly countries. Which hosts (13) visiting professors of doctors from different countries of the world, and these scientific efforts are within the vision of the Kingdom 2030.
His Highness added that this hypothetical scientific meeting comes in light of the difficult global conditions of the Corona pandemic that disrupted many aspects of normal life. Among those working in the field of ophthalmology. This virtual meeting reviews the most important new developments in the specialties of ophthalmology, optometry and combating visual impairment, in which members of the association and a large number of participants and followers participate, with the participation of international and national medical companies in the virtual medical exhibition accompanying this specialized scientific meeting.
In conclusion, in the name of all the participants, I extend my gratitude and gratitude to the Custodian of the Two Holy Mosques King Salman bin Abdulaziz - may God support him - and His Highness, the trustworthy Crown Prince - may God protect him - for what they provide for the care of medicine in general and ophthalmology in particular and for the distinguished position of the Kingdom of Saudi
